Skip to main content

RT @KDAO2011: "If your partner won't use protection, close the vault!" - Dr. J Patricia Dhar interviewed on sexual Heal

Social Author Name
TheDaoIndex
Tweet Content
"If your partner won't use protection, close the vault!" - Dr. J Patricia Dhar interviewed on sexual Health and STD Prevention in Lupus Patients. Contact her pdhar@med.wayne.edu if you want to collaborate or fund her studies. #ACR22 @rheumnow https://t.co/WDLq9Mhoiw

RT @drdavidliew: Does curcurmin (tumeric) do anything in RA? Big talk & sales. Best chance would be keeping pts in

Social Author Name
David Liew
Tweet Content
Does curcurmin (tumeric) do anything in RA? Big talk & sales. Best chance would be keeping pts in remission during csDMARD taper: DBRCT n=200 52w, high bioavail form, good serum conc Absolutely nothing vs placebo I'll call it: just doesn't work in RA ABST1587 #ACR22 @RheumNow https://t.co/wecEfkXT55

RT @RichardPAConway: Flood @FloodRachael et al. ULT reduces non-episodic foot pain in hyperuricaemic patients who fail t

Social Author Name
Richard Conway
Tweet Content
Flood @FloodRachael et al. ULT reduces non-episodic foot pain in hyperuricaemic patients who fail to meet gout classification criteria. Predicted by double counter or tophus on US. @RheumNow #ACR22 Abstr#1828 https://t.co/iOy0Vo5HVO https://t.co/vF98DFB7hJ

RT @RichardPAConway: McCormick et al Fruit juice and other sugar-sweetened drinks increase gout flare in dose-dependent

Social Author Name
Richard Conway
Tweet Content
McCormick et al Fruit juice and other sugar-sweetened drinks increase gout flare in dose-dependent manner @RheumNow #ACR22 Abstr#1805 https://t.co/aGg5i5XyTK https://t.co/x8ChwASM6P

A Novel Treatment Response Measurement Tool for Lupus Dr. Dao discusses abstract 2054 with Dr. Morand at the #ACR22 Co

Social Author Name
Dr. John Cush
Tweet Content
A Novel Treatment Response Measurement Tool for Lupus Dr. Dao discusses abstract 2054 with Dr. Morand at the #ACR22 Convergence. Abstract 2054: Towards a Novel Clinician-Reported Outcome Measure for SLE – Outcomes of an International Consensus Process. https://t.co/iqqyI953Vz https://t.co/taUjTHsrJ2

RT @drdavidliew: Even young SLE patients are still at high risk of severe COVID: - in general pop, age is key factor - i

Social Author Name
David Liew
Tweet Content
Even young SLE patients are still at high risk of severe COVID: - in general pop, age is key factor - in SLE, risk is high across age groups (maybe due to both meds & disease) - vaccination makes a big diff but SLE pts still at high risk ABST1591 @CCalabreseDO #ACR22 @RheumNow https://t.co/ra1F79ITn3

RheumNow’s expanded coverage of the #ACR22 annual meeting is sponsored in part by Novartis. All content chosen by Rhe

Social Author Name
Dr. John Cush
Tweet Content
RheumNow’s expanded coverage of the #ACR22 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its faculty.
Vaccine Efficacy in Patients with Seronegative Spondyloarthritis

Vaccine efficacy remains an important and highly discussed topic at this year’s annual meeting given the ongoing COVID-19 global health crisis, current influenza season, and recently published 2022 ACR guidelines for vaccinations in patients with rheumatic and musculoskeletal diseases.

RT @Yuz6Yusof: #ACR22 Abstr#1830 Short attack of arthritis episode is common in Familial Mediterranean Fever. Other poin

Social Author Name
Md Yuzaiful Md Yusof
Tweet Content
#ACR22 Abstr#1830 Short attack of arthritis episode is common in Familial Mediterranean Fever. Other pointers? A cohort study in Turkey showed to consider FMF in pts with red mono-oligo arthritis in lower limbs & spondyloarthropathy. 20% were colchicine resistant @RheumNow https://t.co/JXGcgCrhPu
Subscribe to
×